Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

28.32USD
28 Jun 2016
Change (% chg)

$1.08 (+3.96%)
Prev Close
$27.24
Open
$27.52
Day's High
$28.34
Day's Low
$27.01
Volume
1,408,594
Avg. Vol
615,772
52-wk High
$44.38
52-wk Low
$27.01

Richard, Ronald 

Mr. Ronald B. Richard is Lead Independent Director of Emergent BioSolutions Inc. Mr. Richard has served as a director since January 2005. Mr. Richard has served as the president and chief executive officer of the Cleveland Foundation, the nation’s oldest community foundation, since June 2003. From August 2002 to February 2003, Mr. Richard served as president of Stem Cell Preservation, Inc., a start-up medical research company. After leaving Stem Cell Preservation and prior to joining Emergent BioSolutions, Mr. Richard served as a strategic business advisor for IGEN International, Inc., a biotechnology company. Mr. Richard served as chief operating officer of In-Q-Tel, a venture capital fund that provides technologies to the Central Intelligence Agency, from March 2001 to August 2002. Prior to joining In-Q-Tel, Mr. Richard served in various senior management positions at Matsushita Electric (Panasonic), a consumer electronics company. Mr. Richard is a former U.S. foreign service officer. He served in Osaka/Kobe, Japan and as a desk officer for North Korean, Greek and Turkish affairs at the U.S. Department of State in Washington, D.C. Mr. Richard previously served as chairman of the board of trustees of the International Biomedical Research Alliance, an academic joint venture among the NIH, Oxford University and Cambridge University. Mr. Richard received an M.A. in international relations from Johns Hopkins University School of Advanced International Studies and a B.A. in history from Washington University. He holds honorary doctorates from Notre Dame College and Baldwin Wallace College.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fuad El-Hibri

3,591,370

Daniel Abdun-Nabi

4,147,390

Robert Kramer

1,917,990

Adam Havey

1,241,980

Ronald Richard

--

Sue Bailey

--
As Of  30 Dec 2014